ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Adult Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,648Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 59

$897K Total Retail Price of All Prescriptions

Rank: 7 out of 59

895 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 895 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

26% of this provider’s 895 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 6,151 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$104 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

10 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 523 322 S3 1 5
SIMVASTATIN 274 192 2 1
ALENDRONATE SODIUM 267 256 3 20
NEXIUM 257 170 4 14
AMLODIPINE BESYLATE 238 192 5 4
LEVOTHYROXINE SODIUM 215 160 6 3
ZOLPIDEM TARTRATE 201 146 7 17
LISINOPRIL 174 127 8 2
SERTRALINE HCL 170 145 9 22
METFORMIN HCL 166 122 10 6
OMEPRAZOLE 155 104 11 7
FUROSEMIDE 151 129 12 8
CRESTOR 147 96 13 23
JANUVIA 132 73 14 45
METOPROLOL SUCCINATE 120 99 15 12
ATORVASTATIN CALCIUM 119 111 16 15
LYRICA 112 62 17 71
METOPROLOL TARTRATE 112 76 17 9
DIOVAN 107 85 19 38
TAMSULOSIN HCL 101 79 20 27
PEN NEEDLE 100 70 21 92
LANTUS 91 74 22 53
JANUMET 88 68 23 117
HYDROCHLOROTHIAZIDE 87 63 24 11
GABAPENTIN 86 65 25 13
DIOVAN HCT 72 67 26 65
AZITHROMYCIN 72 53 26 32
PRAVASTATIN SODIUM 68 47 28 21
LOSARTAN POTASSIUM 68 49 28 19
VOLTAREN 66 55 30 149
LOSARTAN-HYDROCHLOROTHIAZIDE 65 62 31 39
CYMBALTA 64 31 32 57
FAMOTIDINE 64 56 32 66
GLYBURIDE-METFORMIN HCL 63 46 R 34 59
INSULIN SYRINGE 61 37 35 67
LANTUS SOLOSTAR 60 46 36 103
CIPROFLOXACIN HCL 58 43 37 36
HYDRALAZINE HCL 54 37 38 98
CLOPIDOGREL 53 36 39 35
LEVEMIR FLEXPEN 53 32 39 125
LUNESTA 51 45 41 237
AMOX TR-POTASSIUM CLAVULANATE 51 30 41 172
MUPIROCIN 50 31 43 153
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.